FDA
approval
· 2023-04-25
FDA Approved: TELMISARTAN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
The FDA approved a supplemental application for Telmisartan submitted by Glenmark Pharmaceuticals Inc., USA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TELMISARTAN (TELMISARTAN)